This Walmart Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose

Bill Ackman backed Mark Cuban's drug pricing model. Here's which healthcare stocks could benefit—and which face pressure.

FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients

Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today

The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.

Can Cigna's Smart Coverage Help Close Health-Cost Gaps?

Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.

Lululemon’s Margin Problem Could Spell Trouble for These ETFs

Lululemon's margin pressure raises concerns for consumer ETFs as weak sales, tariffs, and competition test retail profitability.

Lululemon Stock Hits 8-Year Low Days Before New CEO Walks in — Gary Black Points to the 4-Month Mistake

Lululemon stock is trading lower after Q2 results and forward guidance. Market expert Gary Black has several reason that might explain weakness.